BioMedGPS announces expanded coverage of SmartTRAK Business Intelligence for the Surgical Wound Market with the addition of its newest module, US Hemostats & Sealants.

Reducing the recurrence of diabetic foot ulcers (DFU) or increasing ulcer free days is critical for patients with diabetes, as recurrence rates are 40% at one year, 66% at three years, and 75% at five years. At the DF Con meeting in Houston in March, BioMedGPS interviewed David G. Armstrong, DMP, MD, PhD, regarding his research on the use of fat grafting as a means to reduce recurrence of DFUs. Today, fat grafting is being rapidly adopted in plastic and reconstructive surgery, but is now being explored for care of the diabetic foot.

SmartTRAK will be at this year's #AVA2017 Association for Vascular Access 2017 Annual Scientific Meeting in Phoenix, Arizona. This year's conference promises to be invaluable for industry learnings and networking. Susan Paquette, VP & General Manager SmartTRAK Wound, will also be in attendance, covering the latest research and technologies and participating in this year's informative agenda.

Doug Devens has joined SmartTRAK to cover new Hemostats & Sealants area including Surgical Matrices

SmartTRAK is happy to introduce you to the newest member of the SmartTRAK team, Doug Devens, PhD. Doug will be heading up our Biosurgery efforts, including our newest segment in Advanced Wound Care, Hemostats and Sealants; and Surgical Matrices – both Hernia and Breast. The new Hemostats & Sealants area covers over 27 companies and 55 products on a global basis, with several currently in development.

Doug Devens
Advanced Wound Care Analyst, Biosurgery

Continued Shift from Biologic to Synthetic Mesh

Innovation and clinical outcomes are shaping the future of the US ventral hernia market. Over the next several years, the market will see a continued shift from biologic mesh to synthetic mesh, growth in robotic hernia repairs, and an increased focus on clinical efficacy and economic outcomes data that will drive product adoption and impact market shares, particularly in the biosynthetic segment.

SmartTRAK just returned from the May 3-5, 2017 EWMA European Wound Management Association Meeting held in Amsterdam.  Great conference! Our very own Susan Paquette,  Vice President and General Manager, Wound for SmartTRAK spoke at the Wound Innovation Symposium on the "State of the Wound Care Market."  We will have an excerpt of the speech up on the blog soon, with the full post of the speech including slides, posted on SmartTRAK.net for our subscribers.

In the meantime, Susan and team have shared a few photos from the conference!

SmartTRAK's Tim Jeavons, Susan Paquette and Lennart Stadler (left to right) attending the 27th conference of European Wound Management Association.  SmartTRAK has local experts in the EU to keep on top of events and news from Europe.  

SmartTRAK is pleased to announce that its Advanced Wound Care Market Intelligence data now includes both Europe and Asia. 

SmartTRAK is inviting its subscribers and colleagues to a special event, the Wound Care Innovation Symposium, being held during EWMA (European Wound Management Association) in Amsterdam on May 4, 2017 from 3pm to 7pm. Susan Paquette, Vice President and General Manager of Wound, SmartTRAK-BioMedGPS, will be presenting the "State of the Wound Care Market" during the event. The full agenda can be found at Symposium Agenda.

Susan Paquette, BioMedGPS/SmartTRAK, President and General Manager Wound, shared trends in Global Advanced Wound Care, at SAWC ( Symposium on Advanced Wound Care Spring) in San Diego, CA during SmartTRAK's private Executive Briefing on April 5, 2017.